HMGB1 and necrotizing enterocolitis: However, levels of stool HMGB1 were not substantially different between infants with NEC stage II and III, which further highlights the need for greater research in the area to identify relevant biomarkers (Liu et al. 2022; Nofi et al. 2024c).